Cellular Orthopedics Blog
On the results of injecting Bone Marrow Concentrate into the joint and into the adjacent bone for osteoarthritis
Options for treating patients with osteoarthritis of their joints are historically limited to pain medication, anti-inflammatory medications, steroids, physical therapy, chiropractic care, or any combination thereof. These treatments provide temporary symptom...
Some Stem Cell Background Observations
There are approximately 2,500 Adult Mesenchymal Stem Cells per mL of Bone Marrow Concentrate on average according to the work of Dr. Phillipe Hernigou in Paris. It leads me to conclude that unconcentrated bone marrow aspirate doesn’t have enough MSCs per unit volume...
When is a Bone Marrow Concentrate Intervention a Failure?
Last week, a patient who had enrolled in the initial Regenexx Stem Cell Clinical Trial for an arthritic knee visited the office for his five year follow up. He had never paid a nickel out of pocket other than obligatory office co-pays for the intervention. Five years...
Regenerative Medicine over exposure
The Blog this week was inspired by the phone call from a patient cancelling his scheduled Bone Marrow Concentrate/Stem cell procedure because he had heard about a superior alternative; namely, a white cell concentrate injection for arthritis. My initial response, “no...
Cellular Orthopedics versus The Regenerative Medicine Charlatans
In reviewing the plethora of proliferating Regenerative Medicine web sites, I found one with multiple points of service in metropolitan Chicago offering platelet rich plasma, fat graft, adipose derived stem cells and bone marrow derived stem cells in an office setting...
Discovering new pathways to healing with stem cells
On October 28, 2013, I received IRB approval for a clinical trial with Regenexx Sciences, LLC as the sponsor and me as the Principal Investigator. The study, A Randomized Controlled Trial of Regenexx SD versus Exercise Therapy for Treatment of Knee Osteoarthritis with...
Evidence Based Medicine and Looking Back at 2016 Interventional Orthopedics
I use bone marrow derived stem cells because they have been proven to be most effective at treating orthopedic conditions when compared to adipose derived stem cells. There have been 13 papers published showing bone marrow superiority to adipose tissue in regards to...
What next?
You no longer will even need a physician, and I have been wasting my Blog space crusading about quality assurance; making certain your Regenerative Medicine specialist is Board Certified and willing to provide outcomes data. According to a recent email I received,...
The Triumph of Falsehood
I started the day by reading the Steve Chapman article appearing in the Perspective Section of the Chicago Tribune, Thursday December 8. The title of my Blog this week is influenced by the header of his article and I admit I am paraphrasing some of that content. While...
A Word on the Future of Cellular Orthopedics
Actually, that future started last week when we used a more aggressive PRP adjunct at the time of two Bone Marrow Concentrate/ Stem Cell interventions; one for an arthritic hip and the other, in an arthritic knee. More accurate and descriptive would be a Bone Marrow...
The Amniotic Fluid marketing campaign
The current marketing of amniotic fluid as a regenerative approach to arthritis based on delivery of viable stem cells falls is no different than the bending of the truth behavior we recently experienced in the run up to the presidential election. Did the campaigns of...
The case for a repeat Bone Marrow Concentrate intervention
This week, I am repeating stem cell/growth factor interventions in two patients; one with arthritis of the hip, and the other with osteoarthritis of both knees. Four years ago, at the initiation of my interventional orthopedic practice, I spoke of adult mesenchymal...